Biomaterials in the treatment of Parkinson's disease

α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

Maria Grazia Spillantini, R. Anthony Crowther, Ross Jakes et al. · Proceedings of the National Academy of Sciences · 1998 · 3.2K citations

Life Sciences, Neurobiology, Neuroscience +17

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

Patrick L. McGeer, Shigeru Itagaki, Barry E. Boyes et al. · Neurology · 1988 · 3K citations

Life Sciences, Neurology, Neuroscience +17

Mitochondrial Complex I Deficiency in Parkinson's Disease

Anthony H.V. Schapira, Jonathan M. Cooper, David T. Dexter et al. · Journal of Neurochemistry · 1990 · 2.3K citations

Life Sciences, Neurobiology, Neuroscience +13

Exosomes as drug delivery vehicles for Parkinson's disease therapy

Matthew J. Haney, Natalia L. Klyachko, Yuling Zhao et al. · Journal of Controlled Release · 2015 · 2K citations · Full text

Life Sciences, Neuroscience, Pharmaceutics +14

Dendrimers: synthesis, applications, and properties

Elham Abbasi, Sedigheh Fekri Aval, Abolfazl Akbarzadeh et al. · Nanoscale Research Letters · 2014 · 1.2K citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Pharmaceutics +14